HDFC Pharma and Healthcare Fund: AUM ₹766 Cr, expense ratio 1.03%, 1Y return +22.64%. Track returns, risk and NAV history.
| Fund House (AMC) | HDFC Mutual Fund |
|---|---|
| Category | Equity Scheme - Sectoral/ Thematic |
| Scheme Code | 152082 |
| ISIN | INF179KC1HO1 |
| AUM | ₹766 Cr |
| Expense Ratio | 1.03% |
| Launch Date | 14-09-2023 (3.2 yrs) |
| 1-Year Return | +22.64% |
| 3-Year Return | +30.37% |
| Alpha (vs Nifty 50) | +28.05% |
| Standard Deviation | 13.72% |
| Sortino Ratio | 1.76 |
| Exit Load | Entry Load: NA Exit Load: In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 1 year from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 1 year from the date of allotment. |
You can check the live AMFI NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan (Scheme Code: 152082) on this page or in our Live Data scanner.
The expense ratio of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 1.03% per annum, deducted daily from the scheme's Net Asset Value (NAV).
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan manages Assets Under Management (AUM) of approximately ₹766 Cr and was launched on 14-09-2023.
Trailing annualized returns for HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 1-Year: +22.64%, 3-Year: +30.37%. Past performance is not indicative of future results.
The AMFI scheme code for HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 152082 and its ISIN is INF179KC1HO1. It is managed by HDFC Mutual Fund.